Literature DB >> 29738812

Dosimetry of inhaled elongate mineral particles in the respiratory tract: The impact of shape factor.

Bahman Asgharian1, T Price Owen2, Eileen D Kuempel3, Annie M Jarabek4.   

Abstract

Inhalation exposure to some types of fibers (e.g., asbestos) is well known to be associated with respiratory diseases and conditions such as pleural plaques, fibrosis, asbestosis, lung cancer, and mesothelioma. In recent years, attention has expanded to other types of elongate mineral particles (EMPs) that may share similar geometry with asbestos fibers but which may differ in mineralogy. Inhalability, dimensions and orientation, and density are major determinants of the aerodynamic behavior for fibers and other EMPs; and the resultant internal dose is recognized as being the critical link between exposure and pathogenesis. Insufficient data are available to fully understand the role of specific physicochemical properties on the potential toxicity across various types of fiber materials. While additional information is required to assess the potential health hazards of EMPs, dosimetry models are currently available to estimate the initially deposited internal dose, which is an essential step in linking airborne exposures to potential health risks. Based on dosimetry model simulations, the inhalability and internal dose of EMPs were found to be greater than that of spherical particles having the same mass or volume. However, the complexity of the dependence of internal dose on EMPs dimensions prevented a straightforward formulation of the deposition-dimension (length or diameter) relationship. Because health outcome is generally related to internal dose, consideration of the factors that influence internal dose is important in assessing the potential health hazards of airborne EMPs.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asbestos; Dosimetry modeling; Elongate mineral particles (EMPs); Fibers; High aspect ratio; Inhalation; Nanotubes; Respiratory; Risk assessment

Mesh:

Substances:

Year:  2018        PMID: 29738812      PMCID: PMC6329593          DOI: 10.1016/j.taap.2018.05.001

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  48 in total

Review 1.  Mineral fibers: chemical, physicochemical, and biological properties.

Authors:  J S Harington; A C Allison; D V Badami
Journal:  Adv Pharmacol Chemother       Date:  1975

2.  The inertial behavior of fibers.

Authors:  W A Burke; N Esmen
Journal:  Am Ind Hyg Assoc J       Date:  1978-05

3.  Statistical analysis of aerosol deposition in nose and mouth.

Authors:  C P Yu; C K Diu; T T Soong
Journal:  Am Ind Hyg Assoc J       Date:  1981-10

Review 4.  Asbestos: when the dust settles an imaging review of asbestos-related disease.

Authors:  Huw D Roach; Gareth J Davies; Richard Attanoos; Michael Crane; Haydn Adams; Siân Phillips
Journal:  Radiographics       Date:  2002-10       Impact factor: 5.333

5.  The biological effects of magnesium-leached chrysotile asbestos.

Authors:  A Morgan; P Davies; J C Wagner; G Berry; A Holmes
Journal:  Br J Exp Pathol       Date:  1977-10

6.  An epidemiological study of the role of chrysotile asbestos fibre dimensions in determining respiratory disease risk in exposed workers.

Authors:  L Stayner; E Kuempel; S Gilbert; M Hein; J Dement
Journal:  Occup Environ Med       Date:  2007-12-20       Impact factor: 4.402

7.  Malignant mesothelioma induced by asbestos and zeolite in the mouse peritoneal cavity.

Authors:  Y Suzuki; N Kohyama
Journal:  Environ Res       Date:  1984-10       Impact factor: 6.498

8.  Correlation between particle size, in vivo particle persistence, and lung injury.

Authors:  G Oberdörster; J Ferin; B E Lehnert
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

9.  Erionite exposure and mesotheliomas in rats.

Authors:  J C Wagner; J W Skidmore; R J Hill; D M Griffiths
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

10.  The asbestos fibre burden in human lungs: new insights into the chrysotile debate.

Authors:  Inke Sabine Feder; Iris Tischoff; Anja Theile; Inge Schmitz; Rolf Merget; Andrea Tannapfel
Journal:  Eur Respir J       Date:  2017-06-29       Impact factor: 16.671

View more
  6 in total

Review 1.  Human exposure to metals in consumer-focused fused filament fabrication (FFF)/ 3D printing processes.

Authors:  Getachew Tedla; Annie M Jarabek; Peter Byrley; William Boyes; Kim Rogers
Journal:  Sci Total Environ       Date:  2021-12-25       Impact factor: 7.963

2.  3D Printer Particle Emissions: Translation to Internal Dose in Adults and Children.

Authors:  Peter Byrley; William K Boyes; Kim Rogers; Annie M Jarabek
Journal:  J Aerosol Sci       Date:  2021-05-01       Impact factor: 4.586

3.  Modelled lung deposition and retention of welding fume particles in occupational scenarios: a comparison to doses used in vitro.

Authors:  Sarah McCarrick; Hanna L Karlsson; Ulrika Carlander
Journal:  Arch Toxicol       Date:  2022-02-21       Impact factor: 5.153

Review 4.  Pulmonary Toxicity of Silica Linked to Its Micro- or Nanometric Particle Size and Crystal Structure: A Review.

Authors:  Vanessa Marques Da Silva; Manon Benjdir; Pierrick Montagne; Jean-Claude Pairon; Sophie Lanone; Pascal Andujar
Journal:  Nanomaterials (Basel)       Date:  2022-07-13       Impact factor: 5.719

5.  Tackling Complex Analytical Tasks: An ISO/TS-Based Validation Approach for Hydrodynamic Chromatography Single Particle Inductively Coupled Plasma Mass Spectrometry.

Authors:  Yves U Hachenberger; Daniel Rosenkranz; Fabian L Kriegel; Benjamin Krause; René Matschaß; Philipp Reichardt; Jutta Tentschert; Peter Laux; Norbert Jakubowski; Ulrich Panne; Andreas Luch
Journal:  Materials (Basel)       Date:  2020-03-22       Impact factor: 3.623

6.  In Silico Optimization of Fiber-Shaped Aerosols in Inhalation Therapy for Augmented Targeting and Deposition across the Respiratory Tract.

Authors:  Lihi Shachar-Berman; Saurabh Bhardwaj; Yan Ostrovski; Prashant Das; Pantelis Koullapis; Stavros Kassinos; Josué Sznitman
Journal:  Pharmaceutics       Date:  2020-03-05       Impact factor: 6.525

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.